Location History:
- Gladesville, AU (1995)
- Helensvale, AU (1995)
Company Filing History:
2 out of 16 
2 out of 150 
Years Active: 1995
Title: The Innovations of Peter L Devine
Introduction
Peter L Devine is a notable inventor based in Gladesville, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of novel proteins and their applications in cancer treatment. With a total of 2 patents, his work has garnered attention for its potential impact on medical science.
Latest Patents
Devine's latest patents include "Minactivin compositions and antibodies to minactivin." This innovative work focuses on a novel human protein known as minactivin, which can be produced through recombinant DNA technology. The research highlights the purification of biologically active native minactivin, as well as peptides derived from it and their amino acid sequences. Additionally, the patent discusses the role of Human PAI-2, a protein that acts as an inactivator of urokinase-type plasminogen activator, which is associated with invasive tumors. This discovery indicates that minactivin is crucial for the body's defense against tumor invasion and metastasis. The methods outlined in the patent provide a pathway for the production of PAI-2 in large quantities, which may be utilized for the diagnosis and treatment of tumors.
Career Highlights
Throughout his career, Peter L Devine has worked with prominent organizations such as Biotechnology Australia Pty Ltd and The Australian National University. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Devine has collaborated with notable colleagues, including Toni Marie Antalis and Neil H Goss. These partnerships have further enriched his research endeavors and have played a role in the successful development of his patented technologies.
Conclusion
Peter L Devine's contributions to biotechnology, particularly through his patents on minactivin and its applications, showcase his innovative spirit and dedication to advancing medical science. His work continues to hold promise for future developments in cancer treatment and diagnosis.